AzTrials
AzTrials

Critical IllnessNCT02408250

Tolerance of Early Exercise in Intensive Care Unit

An observational study of Critical Illness, run by University Hospital, Clermont-Ferrand at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Practice guidelines recommend early physical therapy in intensive care unit. Feasibility, safety and efficacy are confirmed by growing evidence based data. However, the scientific literature emphasizes the heterogeneity of targeted populations, lack of precisions concerning eligibility criteria, program modalities… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Critical Illness
What is being tested?
Exercise program
Type of treatment
Surgery or procedure
How many people
30 participants
Where
1 siteFrance
Study dates
Apr 2015to 31 Oct 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: critical care unit patients

Who may be able to join

  • Men and women
  • Over 18 years old
  • Hospitalized in intensive care unit
  • Patients whose clinical condition allows initiating an early exercise program from critical care physician inclusion

Who cannot join

  • Less than 18 years old or disabled adult
  • Head or spinal severe trauma
  • Severe trauma of the lower limbs or pelvis
  • Musculoskeletal and neurological conditions which do not permit to realise the exercise program
  • Patient for whom the reason for hospitalization does not justify early physical therapy

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Clermont-Ferrand

    Clermont-Ferrand, 63003

Other trials in France

About this study

Practice guidelines recommend early physical therapy in intensive care unit. Feasibility, safety and efficacy are confirmed by growing evidence based data. However, the scientific literature emphasizes the heterogeneity of targeted populations, lack of precisions concerning eligibility criteria, program modalities, timing initiation, progressions and stopping criteria. However, all these results remain to be precised and confirmed. So, the investigators hypothesize that an early exercise program in intensive care unit formalized from a decisional algorithm is well tolerated in clinical practice.

Read the detailed description

Practice guidelines recommend early physical therapy in intensive care unit. Feasibility, safety and efficacy are confirmed by growing evidence based data. However, the scientific literature emphasizes the heterogeneity of targeted populations, lack of precisions concerning eligibility criteria, program modalities, timing initiation, progressions and stopping criteria. However, all these results remain to be precised and confirmed. So, the investigators hypothesize that an early exercise program in intensive care unit formalized from a decisional algorithm is well tolerated in clinical practice.

Being tested
Exercise program
Keywords
algorithm, critical illness, early exercise, feasibility, intensive care unit, physical therapy
Medical subject headings
Critical Illness, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise programProcedure or surgery

    Exercise program in intensive care unit established from a decisional algorithm and applied to the critical care unit patients

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Score difference on a discomfort visual analogic scale between before and after program completion

    Measured: at day 1

Secondary outcomes (4)
  1. Functional capacity (PFIT: Physical Function ICU Test score)

    Measured: at day 1

  2. length of stay on intensive care unit

    Measured: at day 1

  3. mortality in ICU

    Measured: at day 1

  4. Unit of discharge (specialty of the unit)

    Measured: at day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2015 (estimated)
  2. Study startApr 2015
  3. Primary completion31 Oct 2018
  4. Study completion31 Oct 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02408250
Sponsor's protocol ID
CHU-0226
Status last verified
Feb 2019
First submitted
16 Mar 2015
Last updated
20 Feb 2019
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Critical Illness, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Score difference on a discomfort visual analogic scale between before and after program completion (time frame: at day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in